Usana Health Sciences Inc (USNA) Gross Profit Margin starting from the second quarter 2026 to second quarter 2025, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket
 


Usana Health Sciences Inc   (NYSE: USNA)


Usana Health Sciences Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics



USNA Gross Profit Margin (Jul 04 2026)
Q2
(Apr 04 2026)
Q1
(Jan 03 2026)
Q4
(Sep 27 2025)
Q3
(Jun 28 2025)
Q2
Y / Y Revenue Change -5.26 %
Seq. Revenue Change -10.61 %
Revenue In Millions $223.27
Gross Profit Margin 78.35 %
Gross Profit Margin Total Ranking # 786
Gross Profit In Millions $174.93
Y / Y Gross Profit Change -5.78 %
Seq. Gross Profit Change -8.31 %


Commenting Second Quarter 2026 Gross Profit Margin
Usana Health Sciences Inc increased Gross Profit Margin through reduction in Cost of Sales and despite contraction in Gross Profit by -8.31 % and Revenue by -10.61 %. Gross Profit Margin in Q2 was 78.35 %, below company average.


Observing second quarter 2026 results within Legal Cannabis industry 2 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from 745 to 786.
Learn about Gross Margin
USNA's Gross Profit Margin second quarter 2026 Company Ranking
Within: No.
Legal Cannabis Industry # 3
Consumer Non Cyclical Sector # 10
Overall # 780

Gross Profit Margin Statistics
High Average Low
83.54 % 81.53 % 76.38 %
(Jan 03 2015)   (Apr 04 2026)




Other Gross Profit Margin Profitability Ratios
USNA's Cumulative Gross Profit Margin
Legal Cannabis Industry Gross Profit Margin Trends and Statistics
Consumer Non Cyclical Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
USNA's Gross Profit Margin Profitability versus Legal Cannabis Industry, Consumer Non Cyclical Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for USNA's Competitors
Gross Profit Margin Profit Margin for Usana Health Sciences Inc 's Suppliers
Gross Profit Margin Profit Margin for USNA's Customers

You may also want to know
USNA's Annual Growth Rates USNA's Profitability Ratios USNA's Asset Turnover Ratio USNA's Dividend Growth
USNA's Roe USNA's Valuation Ratios USNA's Financial Strength Ratios USNA's Gross Profit Growth
USNA's Roa USNA's Inventory Turnover Ratio USNA's Growth Rates USNA's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Jul 04 2026, within Legal Cannabis Industry Gross Profit MarginJul 04 2026 MRQ Gross ProfitJul 04 2026 MRQ Revenue
Upexi Inc   95.99 %$ 3.023  Millions$ 3.149  Millions
Usana Health Sciences Inc   78.35 %$ 174.934  Millions$ 223.273  Millions
Mannatech Inc  76.87 %$ 20.486  Millions$ 26.650  Millions
Healthy Extracts Inc   70.26 %$ 1.452  Millions$ 2.067  Millions
Biote Corp   64.89 %$ 28.702  Millions$ 44.232  Millions
Niagen Bioscience Inc   64.84 %$ 19.314  Millions$ 29.785  Millions
Trulieve Cannabis Corp.  59.90 %$ 162.289  Millions$ 270.952  Millions
Functional Brands Inc.  59.89 %$ 1.120  Millions$ 1.871  Millions
Adia Nutrition, Inc.  58.22 %$ 0.283  Millions$ 0.485  Millions
Jushi Holdings Inc.  44.22 %$ 31.530  Millions$ 71.297  Millions
Ascend Wellness Holdings, Inc.  36.07 %$ 45.491  Millions$ 126.118  Millions
Tilray Brands Inc   32.13 %$ 90.521  Millions$ 281.714  Millions
Charlie s Holdings Inc   29.41 %$ 1.118  Millions$ 3.802  Millions
Nutra Pharma Corp   26.60 %$ 0.009  Millions$ 0.034  Millions
Cronos Group Inc   23.02 %$ 28.451  Millions$ 123.604  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.